Market Place
Sourcing Support
FDA Accepts sBLA for Dupilumab as Potential BP Treatment
19 Feb 2025 //
PRESS RELEASE
Sanofi gains FDA nod for first biosimilar version of NovoLog
19 Feb 2025 //
FIERCE PHARMA
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3
14 Feb 2025 //
PRESS RELEASE
Sanofi launches Rezurock against chronic Graft-versus-host disease
10 Feb 2025 //
BIOSPECTRUM
Execution of a share buyback agreement for up to €2 billion
08 Feb 2025 //
PRESS RELEASE
Novo fails trial, linking obesity asset to psychiatric effects
06 Feb 2025 //
FIERCE BIOTECH
Mitem Acquires FLISINT Specialty From Sanofi for Rare Diseases
04 Feb 2025 //
BUSINESSWIRE
Sanofi announces buy back of shares from L’Oréal
03 Feb 2025 //
PRESS RELEASE
Q4 sale growth of 10.3%, 2024 business EPS guidance exceeded
31 Jan 2025 //
PRESS RELEASE
Sanofi plans share buybacks, signals more deals post Opella sale
30 Jan 2025 //
REUTERS
Information concerning total number of voting rights & shares
29 Jan 2025 //
GLOBENEWSWIRE
Novo to cap insulin prices in settlement; joins Lilly, Sanofi
28 Jan 2025 //
REUTERS
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
Opella reaches study milestone for Cialis
21 Jan 2025 //
PRESS RELEASE
Sanofi Updates November Voting Rights And Share Information
15 Jan 2025 //
GLOBENEWSWIRE
CEOs encourage `transparency` amid US anti-vaccine push
14 Jan 2025 //
FIERCE PHARMA
Sarclisa Gets First Approval In China For Relapsed Myeloma
13 Jan 2025 //
PRESS RELEASE
Scribe Therapeutics Hits Milestone in Sanofi Collaboration
13 Jan 2025 //
BUSINESSWIRE
Sarclisa Subcutaneous Meets Endpoints In Iraklia Phase 3 Study
09 Jan 2025 //
PRESS RELEASE
Sanofi`s subQ version of Sarclisa measures up to its IV version
09 Jan 2025 //
PRESS RELEASE
LB Pharma`s twist on old Sanofi drug passes schizophrenia test
09 Jan 2025 //
FIERCE BIOTECH
Sanofi partners with Alloy Therapeutics to make new CNS drug
08 Jan 2025 //
PRESS RELEASE
I-Mab pauses Sanofi-partnered to make play for busy CLDN18.2
07 Jan 2025 //
FIERCE BIOTECH
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
Sanofi initiates Ph 3 for PCV21 & expand Collab with SK bioscience
26 Dec 2024 //
PRESS RELEASE
Sanofi pays SK $52M as children`s pneumococcal shot enters Ph 3
24 Dec 2024 //
FIERCE PHARMA
Sanofi scoops up China rights to Cytokinetics’ heart disease med
20 Dec 2024 //
FIERCE BIOTECH
Cytokinetics Announces Sanofi Acquired Aficamten Rights in China
20 Dec 2024 //
GLOBENEWSWIRE
Jean-Paul Kress to join Sanofi`s Board of Directors
19 Dec 2024 //
GLOBENEWSWIRE
New treatments needed in chronic hand eczema
19 Dec 2024 //
FIERCE PHARMA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Teva, Sanofi say bowel disease drug met primary targets
18 Dec 2024 //
PRESS RELEASE
BrightInsight Expands Digital Partnership with Sanofi for Apps
17 Dec 2024 //
GLOBENEWSWIRE
Availability of the Q4 2024 Aide-mémoire
17 Dec 2024 //
GLOBENEWSWIRE
Novavax-Sanofi Deal Hits $50M Milestone In Growth Strategy
14 Dec 2024 //
PR NEWSWIRE
Gilead appoints Sanofi official Dietmar as next CMO
13 Dec 2024 //
REUTERS
Sarclisa Combinations Show Significant Benefits in Myeloma Patients
09 Dec 2024 //
GLOBENEWSWIRE
Sanofi Publishes Revised Financials Excluding Opella
06 Dec 2024 //
GLOBENEWSWIRE
Sanofi to invest $1 bln in insulin production site in Beijing
03 Dec 2024 //
REUTERS
Sanofi Boosts Preparedness With $600 M Singapore Plant
27 Nov 2024 //
BLOOMBERG
Sanofi plans to change hospital drug-discount program
23 Nov 2024 //
REUTERS
Sanofi Reports Voting Rights And Shares - October 2024
20 Nov 2024 //
GLOBENEWSWIRE
Sanofi blueprints €40M manufacturing upgrade in France
19 Nov 2024 //
FIERCE PHARMA
Dupixent sBLA Accepted for FDA in Chronic Spontaneous Urticaria
15 Nov 2024 //
PRESS RELEASE
Sarclisa Recommended for EU Approval for Multiple Myeloma
14 Nov 2024 //
PRESS RELEASE
Sanofi will deploy new AI tool in late-stage MS trials
14 Nov 2024 //
FIERCE BIOTECH
Healx Partners with Sanofi to Explore Rare Disease AI Drug Discovery
13 Nov 2024 //
BUSINESSWIRE
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
11 Nov 2024 //
FIERCE PHARMA
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
11 Nov 2024 //
FIERCE PHARMA
MediciNova Faces Monetary Damages from Sanofi-Novartis Patent
11 Nov 2024 //
GLOBENEWSWIRE
Accumulus Platform Supports Sanofi’s Global Regulatory Submissions
07 Nov 2024 //
GLOBENEWSWIRE
Sanofi`s BTK inhibitor raises platelet 23% of ITP patients
07 Nov 2024 //
FIERCE BIOTECH
Dupixent Approved in EU for Children with Eosinophilic Esophagitis
06 Nov 2024 //
PRESS RELEASE
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Regeneron Reports Q3 2024 Financial and Operating Results
31 Oct 2024 //
GLOBENEWSWIRE
Kymera Therapeutics Reports Q3 2024 Financial Results
31 Oct 2024 //
GLOBENEWSWIRE
Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
28 Oct 2024 //
BUSINESSWIRE
